Laddar populära aktier...
Redeye provides a note following NeoDynamics’ Q1 2024 report.
Redeye comments on Salénterprise’s mandatory bid of all shares in NeoDynamics for SEK1.
Redeye provides a note in relation to NeoDynamics’ Q4 2023 report.
Redeye comments on NeoDynamics’ rights issue of approximately SEK25m.
Yesterday, NeoDynamics released two press releases.
Redeye provides a note in relation to NeoDynamics’ Q3 2023 report and its current financial situation.
Redeye resumes coverage after NeoDynamics’ rights issue.
Redeye briefly comments on NeoDynamics’ rights issue.
Redeye provides an update in relation to NeoDynamics’ Q1 2023 report.
Redeye is positive that NeoDynamics has shipped its CorePulse needles to 23 hospitals in the UK, Germany and Switzerland with expected arriv...
Redeye provides an updated view of NeoDynamics (prompted by a change in analyst) in relation to its Q4’22 report and ahead of the company’s ...
Redeye endorses that NeoDynamics partners with Uniphar for US distribution and logistics.
Redeye lowers its fair value range for NeoDynamics following the continuous assessment of the company’s financial position and an increased ...
Redeye is encouraged by NeoDynamics’ FDA approval for its biopsy instrument NeoNavia and expect a significant initial positive share price r...
Redeye returns with a more detailed take on the Q2 report and concludes that the slow sales ramp-up is likely to spill over onto next year, ...
Redeye returns with a more in-depth take on NeoDynamics following the Q1 report.
Redeye comments on NeoDynamics’ Q1 report and notes several important key activities carried out in the quarter.
Redeye resumes coverage following the rights issue raising SEK 69m for NeoDynamics.
Redeye gives a short comment on the announced rights issue and pauses its coverage.
The number of people affected by breast cancer is expected to grow rapidly in the fore-seeable future.
Redeye welcomes the continued commercial orders for NeoDynamics in Germany and Switzerland.
Redeye provides its take on the Q2 report where we note an encouraging engagement among clinics, though emphasize that there still are diffi...
Redeye views the first commercial order from Germany as intriguing.
Idag, 2021-07-09, meddelade Neodynamics att den första beställningen på ett NeoNavia-system erhållits från Tyskland.
